MLL Münchner Leukämielabor GmbH (MLL)

Abgeschlossene Projekte
• Exploring and exploiting cellular heterogeneity and epigenetic regulation for the interception of myeloid diseases
  01.01.2021 - 31.12.2024

• 2025 Cyclin C promotes development and progression of B-cell acute lymphoblastic leukemia by counteracting p53-mediated stress responses

Download
 RDF/XML-Format
 JSON-LD-Format
 Turtle-Format
 N3-Format